Cardiol Therapeutics INC. 6-K Filing
Ticker: CRDL · Form: 6-K · Filed: Dec 1, 2025 · CIK: 1702123
| Field | Detail |
|---|---|
| Company | Cardiol Therapeutics INC. (CRDL) |
| Form Type | 6-K |
| Filed Date | Dec 1, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Cardiol Therapeutics INC. (ticker: CRDL) to the SEC on Dec 1, 2025.
How long is this filing?
Cardiol Therapeutics INC.'s 6-K filing is 1 pages with approximately 185 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 185 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-12-01 08:05:13
Filing Documents
- form6k.htm (6-K) — 5KB
- exhibit99-1.htm (EX-99.1) — 21KB
- exhibit99-1xu003.jpg (GRAPHIC) — 9KB
- 0001062993-25-017083.txt ( ) — 40KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CARDIOL THERAPEUTICS INC. (Registrant) Date: December 1, 2025 By: /s/ Chris Waddick Chris Waddick Title: Chief Financial Officer